LAUER REGAN J 4
4 · ImmunityBio, Inc. · Filed Dec 16, 2024
Insider Transaction Report
Form 4
LAUER REGAN J
Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2024-12-15+21,031→ 115,365 total - Tax Payment
Common Stock
2024-12-15$2.87/sh−7,503$21,534→ 107,862 total - Exercise/Conversion
Restricted Stock Units
2024-12-15−21,031→ 0 total→ Common Stock (21,031 underlying)
Footnotes (3)
- [F1]On December 15, 2024, the Reporting Person's restricted stock units ("RSUs") vested. The closing price of Immunity Bio, Inc.'s common stock on December 13, 2024 was the settlement price used to calculate the shares withheld.
- [F2]Each RSU represents a contingent right to receive one share of ImmunityBio, Inc. common stock.
- [F3]Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through each applicable vesting date, the RSUs vested as follows: 1/3rd of the RSUs subject to the award vested June 15, 2023, 1/3rd of the RSUs subject to the award vested December 15, 2023, and 1/3rd of the RSUs subject to the award vested December 15, 2024 such that the award was fully vested on December 15, 2024.